Ferenc Scheeren
Ferenc Scheeren
LUMC
Verified email at LUMC.NL
Title
Cited by
Cited by
Year
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
SB Willingham, JP Volkmer, AJ Gentles, D Sahoo, P Dalerba, SS Mitra, ...
Proceedings of the National Academy of Sciences 109 (17), 6662-6667, 2012
10272012
Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming
MJ Kwakkenbos, SA Diehl, E Yasuda, AQ Bakker, CMM Van Geelen, ...
Nature medicine 16 (1), 123-128, 2010
3092010
STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation
SA Diehl, H Schmidlin, M Nagasawa, SD van Haren, MJ Kwakkenbos, ...
The Journal of Immunology 180 (7), 4805-4815, 2008
2602008
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
HE Kohrt, R Houot, K Weiskopf, MJ Goldstein, F Scheeren, D Czerwinski, ...
The Journal of clinical investigation 122 (3), 1066-1075, 2012
2522012
STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression
FA Scheeren, M Naspetti, S Diehl, R Schotte, M Nagasawa, E Wijnands, ...
Nature immunology 6 (3), 303-313, 2005
2332005
Identification of a cKit+ colonic crypt base secretory cell that supports Lgr5+ stem cells in mice
ME Rothenberg, Y Nusse, T Kalisky, JJ Lee, P Dalerba, F Scheeren, ...
Gastroenterology 142 (5), 1195-1205. e6, 2012
2232012
A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF–p53 signaling
A Shvarts, TR Brummelkamp, F Scheeren, E Koh, GQ Daley, H Spits, ...
Genes & development 16 (6), 681-686, 2002
2032002
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway
T Isobe, S Hisamori, DJ Hogan, M Zabala, DG Hendrickson, P Dalerba, ...
Elife 3, e01977, 2014
1482014
IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis
FA Scheeren, SA Diehl, LA Smit, T Beaumont, M Naspetti, RJ Bende, ...
Blood, The Journal of the American Society of Hematology 111 (9), 4706-4715, 2008
1472008
Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B
W Dontje, R Schotte, T Cupedo, M Nagasawa, F Scheeren, R Gimeno, ...
Blood 107 (6), 2446-2452, 2006
1172006
T cell–independent development and induction of somatic hypermutation in human IgM+IgD+CD27+ B cells
FA Scheeren, M Nagasawa, K Weijer, T Cupedo, J Kirberg, N Legrand, ...
The Journal of experimental medicine 205 (9), 2033-2042, 2008
1152008
Single-cell transcriptional diversity is a hallmark of developmental potential
GS Gulati, SS Sikandar, DJ Wesche, A Manjunath, A Bharadwaj, ...
Science 367 (6476), 405-411, 2020
1062020
A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis
FA Scheeren, AH Kuo, LJ Van Weele, S Cai, I Glykofridis, SS Sikandar, ...
Nature cell biology 16 (12), 1238-1248, 2014
1002014
Targeting unique metabolic properties of breast tumor initiating cells
W Feng, A Gentles, RV Nair, M Huang, Y Lin, CY Lee, S Cai, FA Scheeren, ...
Stem cells 32 (7), 1734-1745, 2014
992014
A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages
M Verdoes, LE Edgington, FA Scheeren, M Leyva, G Blum, K Weiskopf, ...
Chemistry & biology 19 (5), 619-628, 2012
982012
Generation of human antigen-specific monoclonal IgM antibodies using vaccinated “human immune system” mice
PD Becker, N Legrand, CMM van Geelen, M Noerder, ND Huntington, ...
PloS one 5 (10), e13137, 2010
872010
Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression
H Schmidlin, SA Diehl, M Nagasawa, FA Scheeren, R Schotte, ...
Blood, The Journal of the American Society of Hematology 112 (5), 1804-1812, 2008
782008
Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRPα axis and a target for cancer immunotherapy
MEW Logtenberg, JHM Jansen, M Raaben, M Toebes, K Franke, ...
Nature medicine 25 (4), 612-619, 2019
732019
CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer
MT Cheah, JY Chen, D Sahoo, H Contreras-Trujillo, AK Volkmer, ...
Proceedings of the National Academy of Sciences 112 (15), 4725-4730, 2015
712015
IL-21 imposes a type II EBV gene expression on type III and type IB cells by the repression of C-and activation of LMP-1-promoter
LL Kis, D Salamon, EK Persson, N Nagy, FA Scheeren, H Spits, G Klein, ...
Proceedings of the National Academy of Sciences 107 (2), 872-877, 2010
702010
The system can't perform the operation now. Try again later.
Articles 1–20